| Trade name of the product: |
| Menomune-A / C / Y / W-135 |
| Pharmaceutical active ingredients: |
| Meningococcal Polysaccharide Antigen Group AMeningococcal Polysaccharide Antigen Group CMeningococcal Polysaccharide Antigen Group W-135Meningococcal Polysaccharide Antigen Group Y |
| Available forms, composition and doses of Menomune-A / C / Y / W-135: |
| Injectable; Injection; Meningococcal Polysaccharide Antigen Group A 0.5 mg; Meningococcal Polysaccharide Antigen Group C 0.5 mg; Meningococcal Polysaccharide Antigen Group W-135 0.5 mg; Meningococcal Polysaccharide Antigen Group Y 0.5 mgInjectable; Injection; Meningococcal Polysaccharide Antigen Group A 2.5 mg; Meningococcal Polysaccharide Antigen Group C 2.5 mg; Meningococcal Polysaccharide Antigen Group W-135 2.5 mg; Meningococcal Polysaccharide Antigen Group Y 2.5 mg |
| Medical categories: |
| Human:Vaccines, antisera and immunologicals |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J07AH04 - Meningococcus A, C, Y, W-135, tetravalent purified polysaccharides antigen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisZuellig Pharma |
| Where to buy Menomune-A / C / Y / W-135 brand or generic online: |
Buy Menomune-A / C / Y / W-135 online
|